Walvax Biotechnology Co Ltd

Common Name
Walvax Biotechnology
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2,388
Ticker
300142
Exchange
SHENZHEN STOCK EXCHANGE
Description
Walvax Biotechnology Co., Ltd. is a leading biopharmaceutical company based in China, focusing on the research, development, and commercialization of vaccines and biopharmaceutical products. Establish...

Walvax Biotechnology's Climate Target Data Preview

As of 2023, Walvax Biotechnology has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 intensity-based target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Walvax Biotechnology ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Intensity-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue
Copy restricted. Please purchase to unlock this data.
2025

This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Walvax Biotechnology's Greenhouse Gas Emissions Pathways

As of 2023, Walvax Biotechnology has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.

Does Walvax Biotechnology have a target to reduce the emissions from its operations?

As of 2023, Walvax Biotechnology has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.

Walvax Biotechnology's most ambitious operational target is to reduce these emissions by 8% by 2025, compared to a baseline of 0 Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue in 2023.

Walvax Biotechnology's Operational (Scope 1+2) Emissions Pathway

2023202500000Target 2025 (-8%)
Want Full Access to Walvax Biotechnology's Climate Targets Dataset?
Sign Up